Proposed Data Collections Submitted for Public Comment and Recommendations, 53310-53311 [2010-21737]
Download as PDF
<![CDATA[
53310
Federal Register / Vol. 75, No. 168 / Tuesday, August 31, 2010 / Notices
Dated: August 20, 2010.
Carolyn M. Clancy,
Director.
use of information technology. Written
comments should be received within 60
days of this notice.
[FR Doc. 2010–21503 Filed 8–30–10; 8:45 am]
Proposed Project
Clostridium difficile Infection (CDI)
Surveillance—New—National Center for
Emerging and Zoonotic Infectious
Diseases, (NCEZID), Centers for Disease
Control and Prevention, (CDC).
BILLING CODE 4160–90–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60 Day 10–10GP]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects.
Alternatively, to obtain a copy of the
data collection plans and instrument,
call 404–639–5960 and send comments
to Maryam I. Daneshvar, CDC Reports
Clearance Officer, 1600 Clifton Road
NE., MS–D74, Atlanta, Georgia 30333;
comments may also be sent by e-mail to
omb@cdc.gov.
Comments are invited on (a) whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have a
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarify of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
difficile toxin and abstract data on cases
using a standardized case report form.
For a subset of cases (e.g., communityassociated C. difficile cases) sites will
administer a health interview. Remnant
stool specimens from cases testing
positive for C. difficile toxin will be
submitted to reference laboratories for
culturing, and isolates will be sent to
CDC for confirmation and molecular
typing. Outcomes of this surveillance
project will include the populationbased incidence of community- and
healthcare-associated CDI, and a
description of the molecular
characteristics of C. difficile strains and
the epidemiology of this infection
among the population under
surveillance.
For this proposed data collection,
there is no cost to respondents other
than their time. An estimated total of
8,750 CDI Surveillance Case Report
Forms (CRFs) will be completed during
a one-year study period. Approximately
4,370 cases will require a completed
CRF taking one hour; the remaining
4,380 cases will only require a partially
completed CRF taking 15 minutes. An
estimated total of 500 CDI Surveillance
Health Interviews (HI) will need to be
completed for the same time period. The
estimated time to complete the HI is 45
minutes. Therefore, the total estimated
annualized burden for this data
collection is 5,840 hours.
The proposed surveillance for CDI
through the Emerging Infections
Program will expand CDC capacity to
monitor incidence of C. difficile in
community and healthcare settings as
well as to monitor and detect
antimicrobial resistance. This activity
supports the HHS Action Plan for
elimination of healthcare-associated
infections.
Background and Brief Description
Steady increases in the rate and
severity of Clostridium difficile
infection (CDI) indicate a clear need to
conduct longitudinal assessments of the
impact of CDI in the United States. C.
difficile is an anaerobic, spore-forming,
gram positive bacillus that produces two
pathogenic toxins: A and B. CDI ranges
in severity from mild diarrhea to
fulminant colitis and death.
Transmission of C. difficile occurs
primarily in healthcare facilities, where
environmental contamination by C.
difficile spores and exposure to
antimicrobial drugs are common. No
longer limited to healthcare
environments, community-associated
CDI is the focus of increasing attention.
Recently, several cases of serious CDI
have been reported in what have been
considered low-risk populations,
including healthy persons living in the
community and peri-partum women.
The surveillance population will
consist of persons residing in the
catchment area of the participating
Emerging Infections Program (EIP) sites.
This surveillance poses no more than
minimal risk to the study participants as
there will be no interventions or
modifications to the care study
participants receive. EIP surveillance
personnel will perform active case
finding from laboratory reports of stool
specimens testing positive for C.
ESTIMATE OF ANNUALIZED BURDEN HOURS
Number of
respondents
Forms
CDI Surveillance Case Report Form—Complete ............................................
CDI Surveillance Case Report Form—Partial .................................................
CDI Surveillance Health Interview ...................................................................
Number of
responses per
respondent
10
10
10
437
438
50
srobinson on DSKHWCL6B1PROD with NOTICES
Total ..........................................................................................................
VerDate Mar<15>2010
16:33 Aug 30, 2010
Jkt 220001
PO 00000
Frm 00040
Fmt 4703
Sfmt 9990
Average
burden per
response
(in hours)
1
15/60
45/60
Total burden
(in hours)
4,370
1,095
375
5,840
E:\FR\FM\31AUN1.SGM
31AUN1
53311
Federal Register / Vol. 75, No. 168 / Tuesday, August 31, 2010 / Notices
Dated: August 25, 2010.
Carol Walker,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. 2010–21737 Filed 8–30–10; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30-Day–10–0798]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
chapter 35). To request a copy of these
requests, call the CDC Reports Clearance
Officer at (404) 639–5960 or send an email to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC or by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
Proposed Project
Health Marketing (OMB No. 0920–
0798, exp. 01/31/2011)—Extension—
Office of the Associate Director for
Communication (OADC), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
Today, CDC is globally recognized for
conducting research and investigations
and for its action oriented approach.
CDC applies research and findings to
improve people’s daily lives and
responds to health emergencies—
something that distinguishes CDC from
its peer agencies.
CDC is committed to achieving true
improvements in people’s health. To do
this, the agency is defining specific
health protection goals to prioritize and
focus its work and investments and
measure progress.
It is imperative that CDC provide
high-quality timely information and
programs in the most effective ways to
help people, families, and communities
protect their health and safety. Through
continuous consumer feedback,
prevention research, and public health
information technology, we identify and
evaluate health needs and interests,
translate science into actions to meet
those needs, and engage the public in
the excitement of discovery and the
progress being made to improve the
health of the Nation. In our outreach to
partners, we build relationships that
model shared learning, mutual trust,
and diversity in points of view and
sectors of society.
OADC is requesting a 3-year extension
of OMB 0920–0798, Health Marketing,
to provide feedback on the
development, implementation and
satisfaction regarding public health
services, products, communication
campaigns and information. The
information will be collected using
standard qualitative and quantitative
methods such as interviews, focus
groups, and panels, as well as
questionnaires administered in person,
by telephone, by mail, by e-mail, and
online. More specific types of studies
may include: User experience and usertesting; concept/product/package
development testing; brand positioning/
identity research; customer satisfaction
surveying; ethnography/observational
studies; and mystery shopping. The data
will be used to provide input to the
development, delivery and
communication of public health
services and information at CDC and to
address emerging programmatic needs.
Every National Center and Office at
CDC will have the opportunity to utilize
this generic clearance. There is no cost
to the respondents other than their time.
The total estimated burden hours are
11,250.
Type of respondents
Number of
respondents
Number of
responses per
respondent
Average burden per response
(in hours)
CDC Partners, Public Health Professionals, Health Care Professionals, General Public ..........
25,000
1
27/60
Dated: August 24, 2010.
Maryam I. Daneshvar,
Reports Clearance Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2010–21736 Filed 8–30–10; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Proposed Project
Centers for Disease Control and
Prevention
srobinson on DSKHWCL6B1PROD with NOTICES
[30-Day–10–0736]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
VerDate Mar<15>2010
16:33 Aug 30, 2010
Jkt 220001
Chapter 35). To request a copy of these
requests, call the CDC Reports Clearance
Officer at (404) 639–5960 or send an email to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC or by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
Human Smoking Behavior Study—
Reinstatement with Change—National
Center for Chronic Disease Prevention
and Health Promotion (NCCDPHP),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
Cigarettes have been ranked as fullflavor, light or ultralight on the basis of
machine-measured levels of smoke
toxins (yield categories). The machinebased methods approximate human
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
smoking patterns under controlled
conditions but may not accurately
reflect conditions of actual use,
moreover, public health data have not
consistently shown differences in health
outcomes among smokers of cigarettes
of different machine-smoked yield
categories.
In 2007, the Centers for Disease
Control and Prevention (CDC) received
OMB approval for a research study
designed to elucidate patterns of human
smoking behavior, quantify biomarkers
of exposure to smoke toxins under
conditions of actual use, and assess how
smoking behavior modifies the
relationship between cigarette yield
category, biomarkers of exposure, and
measures of cardiovascular reactivity
(OMB No. 0920–0736, exp. 3/31/2010).
The study was initiated collaboratively
by the National Center for Chronic
Disease Prevention and Health
Promotion (NCCDPHP) and the National
E:\FR\FM\31AUN1.SGM
31AUN1
]]>Agencies
[Federal Register Volume 75, Number 168 (Tuesday, August 31, 2010)]
[Notices]
[Pages 53310-53311]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-21737]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60 Day 10-10GP]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
Alternatively, to obtain a copy of the data collection plans and
instrument, call 404-639-5960 and send comments to Maryam I. Daneshvar,
CDC Reports Clearance Officer, 1600 Clifton Road NE., MS-D74, Atlanta,
Georgia 30333; comments may also be sent by e-mail to omb@cdc.gov.
Comments are invited on (a) whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have a practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarify of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of information technology. Written comments
should be received within 60 days of this notice.
Proposed Project
Clostridium difficile Infection (CDI) Surveillance--New--National
Center for Emerging and Zoonotic Infectious Diseases, (NCEZID), Centers
for Disease Control and Prevention, (CDC).
Background and Brief Description
Steady increases in the rate and severity of Clostridium difficile
infection (CDI) indicate a clear need to conduct longitudinal
assessments of the impact of CDI in the United States. C. difficile is
an anaerobic, spore-forming, gram positive bacillus that produces two
pathogenic toxins: A and B. CDI ranges in severity from mild diarrhea
to fulminant colitis and death. Transmission of C. difficile occurs
primarily in healthcare facilities, where environmental contamination
by C. difficile spores and exposure to antimicrobial drugs are common.
No longer limited to healthcare environments, community-associated CDI
is the focus of increasing attention. Recently, several cases of
serious CDI have been reported in what have been considered low-risk
populations, including healthy persons living in the community and
peri-partum women.
The surveillance population will consist of persons residing in the
catchment area of the participating Emerging Infections Program (EIP)
sites. This surveillance poses no more than minimal risk to the study
participants as there will be no interventions or modifications to the
care study participants receive. EIP surveillance personnel will
perform active case finding from laboratory reports of stool specimens
testing positive for C. difficile toxin and abstract data on cases
using a standardized case report form. For a subset of cases (e.g.,
community-associated C. difficile cases) sites will administer a health
interview. Remnant stool specimens from cases testing positive for C.
difficile toxin will be submitted to reference laboratories for
culturing, and isolates will be sent to CDC for confirmation and
molecular typing. Outcomes of this surveillance project will include
the population-based incidence of community- and healthcare-associated
CDI, and a description of the molecular characteristics of C. difficile
strains and the epidemiology of this infection among the population
under surveillance.
For this proposed data collection, there is no cost to respondents
other than their time. An estimated total of 8,750 CDI Surveillance
Case Report Forms (CRFs) will be completed during a one-year study
period. Approximately 4,370 cases will require a completed CRF taking
one hour; the remaining 4,380 cases will only require a partially
completed CRF taking 15 minutes. An estimated total of 500 CDI
Surveillance Health Interviews (HI) will need to be completed for the
same time period. The estimated time to complete the HI is 45 minutes.
Therefore, the total estimated annualized burden for this data
collection is 5,840 hours.
The proposed surveillance for CDI through the Emerging Infections
Program will expand CDC capacity to monitor incidence of C. difficile
in community and healthcare settings as well as to monitor and detect
antimicrobial resistance. This activity supports the HHS Action Plan
for elimination of healthcare-associated infections.
Estimate of Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Forms Number of responses per per response Total burden
respondents respondent (in hours) (in hours)
----------------------------------------------------------------------------------------------------------------
CDI Surveillance Case Report Form--Complete..... 10 437 1 4,370
CDI Surveillance Case Report Form--Partial...... 10 438 15/60 1,095
CDI Surveillance Health Interview............... 10 50 45/60 375
---------------------------------------------------------------
Total....................................... .............. .............. .............. 5,840
----------------------------------------------------------------------------------------------------------------
[[Page 53311]]
Dated: August 25, 2010.
Carol Walker,
Acting Reports Clearance Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2010-21737 Filed 8-30-10; 8:45 am]
BILLING CODE 4163-18-P
